NeoGenomics, Inc. Deferred Income Tax Liabilities, Net
NeoGenomics, Inc. (NEO) had Deferred Income Tax Liabilities, Net of $16.82 million as of 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredIncomeTaxLiabilitiesNet · last filed 2026-07-28
- 2026-06-30: Deferred Income Tax Liabilities, Net $16.82M.
- 2026-03-31: Deferred Income Tax Liabilities, Net $17.45M.
- 2025-12-31: Deferred Income Tax Liabilities, Net $18.22M.
- 2025-09-30: Deferred Income Tax Liabilities, Net $20.85M.
| Period end | Deferred Income Tax Liabilities, Net |
|---|---|
| 2026-06-30 | $16.82M 10-Q · filed 2026-07-28 |
| 2026-03-31 | $17.45M 10-Q · filed 2026-04-28 |
| 2025-12-31 | $18.22M 10-Q · filed 2026-07-28 |
| 2025-09-30 | $20.85M 10-Q · filed 2025-10-28 |
| 2025-06-30 | $19.98M 10-Q · filed 2025-07-29 |
| 2025-03-31 | $20.97M 10-Q · filed 2025-04-29 |
| 2024-12-31 | $21.51M 10-K · filed 2026-02-17 |
| 2024-09-30 | $22.77M 10-Q · filed 2024-11-05 |
| 2024-06-30 | $23.02M 10-Q · filed 2024-07-30 |
| 2024-03-31 | $23.49M 10-Q · filed 2024-04-30 |
| 2023-12-31 | $24.29M 10-K · filed 2025-02-18 |
| 2023-09-30 | $25.37M 10-Q · filed 2023-11-06 |
| 2023-06-30 | $28.81M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $31.71M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $34.75M 10-K · filed 2024-02-20 |
| 2022-09-30 | $38.34M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $45.98M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $51.71M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $55.48M 10-K · filed 2023-02-24 |
| 2021-09-30 | $57.71M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $63.88M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $1.74M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $5.42M 10-K · filed 2022-02-25 |
| 2020-09-30 | $13.55M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $15.42M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $16.38M 10-Q · filed 2020-04-29 |
| 2019-12-31 | $15.57M 10-K · filed 2021-02-25 |
| 2019-09-30 | $19.69M 10-Q · filed 2019-11-13 |
| 2019-06-30 | $20.12M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $20.16M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $22.46M 10-K · filed 2020-02-28 |
| 2018-09-30 | $6.90M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $6.83M 10-Q · filed 2018-08-06 |
| 2018-03-31 | $6.59M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $6.69M 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |